Patents by Inventor David W. Buck

David W. Buck has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8084033
    Abstract: Compositions comprising a cell expressing an AC133 cell surface antigen and an antibody, or antigen binding fragment thereof, that specifically binds to the antigen are provided. Expression of the antigen is highly tissue specific. It is detected on a subset of hematopoietic progenitor and stem cells derived from human bone marrow, fetal bone marrow and liver, cord blood and adult peripheral blood. The subset of cells recognized by AC133 is CD34bright and contains substantially all of the CFU-GM activity present in the CD34+ population. This highly specific distribution of AC133 makes it exceptionally useful as a reagent for isolating and characterizing human hematopoietic progenitor and stem cells. Cells selected for expression of AC133 antigen can be further purified by selection for other hematopoietic stem cell and progenitor cell markers.
    Type: Grant
    Filed: July 8, 2008
    Date of Patent: December 27, 2011
    Assignee: Amcell Corporation
    Inventors: Amy H. Yin, Sheri Miraglia, Wayne G. Godfrey, David W. Buck
  • Publication number: 20100086998
    Abstract: Enriched neural stem and progenitor cell populations, and methods for identifying, isolating and enriching for neural stem cells using reagent that bind to cell surface markers, are provided.
    Type: Application
    Filed: September 9, 2009
    Publication date: April 8, 2010
    Inventors: David W. Buck, Nobuko Uchida, Irving Weissman
  • Publication number: 20090093052
    Abstract: A hematopoietic progenitor cell antigen and reagents, notably antibodies, that specifically bind to the antigen are provided. Expression of the antigen is highly tissue specific. It is only detected on a subset of hematopoietic progenitor cells derived from human bone marrow, fetal bone marrow and liver, cord blood and adult peripheral blood. The subset of cells recognized by AC133 is CD34bright and contains substantially all of the CFU-GM activity present in the CD34+ population. This highly specific distribution of AC133 makes it exceptionally useful as a reagent for isolating and characterizing human hematopoietic progenitor and stem cells. Cells selected for expression of AC133 antigen can be further purified by selection for other hematopoietic stem cell and progenitor cell markers.
    Type: Application
    Filed: July 8, 2008
    Publication date: April 9, 2009
    Inventors: Amy H. Yin, Sheri Miraglia, David W. Buck
  • Patent number: 7217565
    Abstract: Enriched neural stem and progenitor cell populations, and methods for identifying, isolating and enriching for neural stem cells using reagent that bind to cell surface markers, are provided.
    Type: Grant
    Filed: July 11, 2002
    Date of Patent: May 15, 2007
    Assignee: StemCells California, Inc.
    Inventors: David W. Buck, Nobuko Uchida, Irving Weissman
  • Patent number: 7153686
    Abstract: Enriched neural stem and progenitor cell populations, and methods for identifying, isolating and enriching for neural stem cells using reagent that bind to cell surface markers, are provided.
    Type: Grant
    Filed: August 9, 2001
    Date of Patent: December 26, 2006
    Assignee: Stemcells California, Inc.
    Inventors: Nobuko Uchida, David W. Buck, Irving Weissman
  • Patent number: 7105150
    Abstract: Enriched neural stem and progenitor cell populations, and methods for identifying, isolating and enriching for neural stem cells using reagent that bind to cell surface markers, are provided.
    Type: Grant
    Filed: February 23, 2001
    Date of Patent: September 12, 2006
    Assignee: StemCells California, Inc.
    Inventors: David W. Buck, Nobuko Uchida, Irving Weissman
  • Patent number: 7037719
    Abstract: Enriched neural stem and progenitor cell populations, and methods for identifying, isolating and enriching for neural stem cells using reagent that bind to cell surface markers, are provided.
    Type: Grant
    Filed: February 11, 2000
    Date of Patent: May 2, 2006
    Assignee: StemCells California, Inc.
    Inventors: David W. Buck, Nobuko Uchida, Irving Weissman
  • Patent number: 6806683
    Abstract: A battery adapter (A) replaces two batteries (10) with a single battery (10) housed within a compartment (48) of a battery powered electrical device (D). An electrically conductive housing (40) adapted to replicate a selected battery and fit within a space adapted to house two of the selected sized batteries. A step up circuit (18) mounted within the battery housing (40) receives an electrical signal from a single battery (10) and transforms the voltage of the electrical signal to simulate an electrical signal from two electrically connected selected batteries (10).
    Type: Grant
    Filed: February 2, 2003
    Date of Patent: October 19, 2004
    Assignee: Litton Systems, Inc.
    Inventors: Michael R. Saldana, David W. Buck, Kenneth W. Sauter
  • Publication number: 20030169607
    Abstract: A battery adapter (A) replaces two batteries (10) with a single battery (10) housed within a compartment (48) of a battery powered electrical device (D). An electrically conductive housing (40) adapted to replicate a selected battery and fit within a space adapted to house two of the selected sized batteries. A step up circuit (18) mounted within the battery housing (40) receives an electrical signal from a single battery (10) and transforms the voltage of the electrical signal to simulate an electrical signal from two electrically connected selected batteries (10).
    Type: Application
    Filed: February 2, 2003
    Publication date: September 11, 2003
    Applicant: LITTON SYSTEMS, INC.
    Inventors: Michael R. Saldana, David W. Buck, Kenneth W. Sauter
  • Publication number: 20030109039
    Abstract: Enriched neural stem and progenitor cell populations, and methods for identifying, isolating and enriching for neural stem cells using reagent that bind to cell surface markers, are provided.
    Type: Application
    Filed: July 11, 2002
    Publication date: June 12, 2003
    Inventors: David W. Buck, Nobuko Uchida, Irving Weissman
  • Patent number: 6468794
    Abstract: Enriched neural stem and progenitor cell populations, and methods for identifying, isolating and enriching for neural stem cells using reagent that bind to cell surface markers, are provided.
    Type: Grant
    Filed: October 21, 1999
    Date of Patent: October 22, 2002
    Assignee: StemCells, Inc.
    Inventors: Nobuko Uchida, David W. Buck, Irving Weissman
  • Patent number: 6455678
    Abstract: A hematopoietic progenitor cell antigen and reagents, notably antibodies, that specifically bind to the antigen are provided. Expression of the antigen is highly tissue specific. It is only detected on a subset of hematopoietic progenitor cells derived from human bone marrow, fetal bone marrow and liver, cord blood and adult peripheral blood. The subset of cells recognized by AC133 is CD34bright and contains substantially all of the CFU-GM activity present in the CD34+ population. This highly specific distribution of AC133 makes it exceptionally useful as a reagent for isolating and characterizing human hematopoietic progenitor and stem cells. Cells selected for expression of AC133 antigen can be further purified by selection for other hematopoietic stem cell and progenitor cell markers.
    Type: Grant
    Filed: April 23, 1997
    Date of Patent: September 24, 2002
    Assignee: AmCell Corporation
    Inventors: Amy H. Yin, Sheri Miraglia, Wayne G. Godfry, David W. Buck
  • Patent number: 6448742
    Abstract: A transportable power source (P) for an image viewing device (D) includes a battery pack housing assembly (10) to internally hold a first battery pack (12). An electrical interface circuit (14) receives an input voltage level (16) and provides a resulting output voltage level (18) as an output therefrom to operate the viewer device (D). The interface circuit (14) receives a selected first input voltage level (20) from the first battery pack (12). Alternatively, the interface circuit (14) receives a selected second input voltage level (22) from a power supply source (S) external to the battery pack housing (10). The interface circuit (14) further includes a switch (24) for selecting between sources of input voltage levels from among at least the first input voltage level (20) and the second input voltage level (22). The switch (24) also selectively controls the source for the resulting output voltage level (18).
    Type: Grant
    Filed: February 15, 2001
    Date of Patent: September 10, 2002
    Assignee: Litton Systems, Inc.
    Inventors: Michael D. Waterman, David W. Buck, Terry D. Morris, James G. Winkel, David A. Crosby
  • Publication number: 20020109481
    Abstract: A transportable power source (P) for an image viewing device (D) includes a battery pack housing assembly (10) to internally hold a first battery pack (12). An electrical interface circuit (14) receives an input voltage level (16) and provides a resulting output voltage level (18) as an output therefrom to operate the viewer device (D). The interface circuit (14) receives a selected first input voltage level (20) from the first battery pack (12). Alternatively, the interface circuit (14) receives a selected second input voltage level (22) from a power supply source (S) external to the battery pack housing (10). The interface circuit (14) further includes a switch (24) for selecting between sources of input voltage levels from among at least the first input voltage level (20) and the second input voltage level (22). The switch (24) also selectively controls the source for the resulting output voltage level (18).
    Type: Application
    Filed: February 15, 2001
    Publication date: August 15, 2002
    Inventors: Michael D. Waterman, David W. Buck, Terry D. Morris, James G. Winkel, David A. Crosby
  • Publication number: 20020031792
    Abstract: Enriched neural stem and progenitor cell populations, and methods for identifying, isolating and enriching for neural stem cells using reagent that bind to cell surface markers, are provided.
    Type: Application
    Filed: August 9, 2001
    Publication date: March 14, 2002
    Inventors: Nobuko Uchida, David W. Buck, Irving Weissman
  • Publication number: 20010051372
    Abstract: A hematopoietic progenitor cell antigen and reagents, notably antibodies, that specifically bind to the antigen are provided. Expression of the antigen is highly tissue specific. It is only detected on a subset of hematopoietic progenitor cells derived from human bone marrow, fetal bone marrow and liver, cord blood and adult peripheral blood. The subset of cells recognized by AC133 is CD34bright and contains substantially all of the CFU-GM activity present in the CD34+ population. This highly specific distribution of AC133 makes it exceptionally useful as a reagent for isolating and characterizing human hematopoietic progenitor and stem cells. Cells selected for expression of AC133 antigen can be further purified by selection for other hematopoietic stem cell and progenitor cell markers.
    Type: Application
    Filed: June 13, 2001
    Publication date: December 13, 2001
    Inventors: Amy H. Yin, Sheri Miraglia, Wayne G. Godfrey, David W. Buck
  • Publication number: 20010044122
    Abstract: Enriched neural stem and progenitor cell populations, and methods for identifying, isolating and enriching for neural stem cells using reagent that bind to cell surface markers, are provided.
    Type: Application
    Filed: February 23, 2001
    Publication date: November 22, 2001
    Inventors: David W. Buck, Nobuko Uchida, Irving Weissman
  • Patent number: 6239587
    Abstract: A probe (10) has a main body (12), an input side (14) and an output side (16). The main body (12) has a cavity (17) to receive an insulator (18). The insulator (18) has a current slit (22) and a voltage slit (24) aligned with a first aperture (30a) and a second aperture (30b). An inner conductor extends through the insulator (18) from the input side (14) to the output side (42) of the main body (12). A current sensor (40) inserts into the first aperture (30a) and the current slit (22). A voltage sensor (50) inserts into the second aperture (30b) and the voltage slit (24). A radio frequency signal on a transmission line having a same impedance as the probe (10) enters the inner conductor (20) at the input side (14), induces a current onto the current sensor (40) and a voltage onto the voltage sensor (50). The induced current and voltage can be measured to monitor the characteristics of the transmission line.
    Type: Grant
    Filed: December 31, 1997
    Date of Patent: May 29, 2001
    Assignee: Texas Instruments Incorporated
    Inventor: David W. Buck
  • Patent number: 5843633
    Abstract: An hematopoietic progenitor cell antigen, and antibodies that specifically bind to the antigen are provided. Expression of the antigen is highly tissue specific. It is only detected on a subset of hematopoietic progenitor cells derived from human bone marrow, fetal bone marrow and liver, cord blood and adult peripheral blood. The subset of cells recognized by AC133 is CD34.sup.bright, and contains substantially all of the CFU-GM activity present in the CD34.sup.+ population. This highly specific distribution of AC133 makes it exceptionally useful as a reagent for isolating and characterizing human hematopoietic progenitor and stem cells. Cells selected for expression of AC133 antigen may be further purified by selection for other hematopoietic stem cell and progenitor cell markers.
    Type: Grant
    Filed: April 26, 1996
    Date of Patent: December 1, 1998
    Assignee: Amcell Corporation
    Inventors: Amy Yin, Sheri Miraglia, David W. Buck
  • Patent number: 5423942
    Abstract: A method and apparatus is provided for reducing wall erosion in a plasma containment tube (20), such as, for example, a quartz plasma tube (20) used in a microwave-induced plasma reaction process for etching semiconductor wafers. A pure benign or non-corrosive gas (Ar) is introduced into the "upstream" section (22a) of the tube (22), where the microwave energy is imparted to create a plasma. The activated benign gas flows "downstream" through a flange (28), preferably made of quartz, which is seated on o-rings (50) inside a water-cooled metal flange (48). These sealing o-rings (50) are thus cooled and removed from the ultraviolet light created by the plasma. The corrosive etchant gas (SF.sub.6) is introduced into the "downstream" section (22b) of the tube (22) beyond the flange (28), where it is activated by the benign gas (Ar). The benign gas (Ar) flows principally along the inner sidewalls of the tube (22), and the etchant gas (SF.sub.
    Type: Grant
    Filed: June 20, 1994
    Date of Patent: June 13, 1995
    Assignee: Texas Instruments Incorporated
    Inventors: Roger A. Robbins, Donald E. Brown, David W. Buck, Alan D. Rose